Jon L. Wright

发表

Discovery of selective dopamine D4 receptor antagonists: 1-Aryloxy-3-(4-aryloxypiperidinyl)-2-propanols

T. Heffner, R. Mackenzie, L. Wise, 1997 .

Synthesis of new acylsulfamoyl benzoxaboroles as potent inhibitors of HCV NS3 protease.

Z. Ni, Suoming Zhang, S. Baker, 2010, Bioorganic & medicinal chemistry letters.

Synthesis and evaluation of novel alpha-amino cyclic boronates as inhibitors of HCV NS3 protease.

Z. Ni, P. Rowland, S. Baker, 2010, Bioorganic & medicinal chemistry letters.

Synthesis and biological evaluations of P4-benzoxaborole-substituted macrocyclic inhibitors of HCV NS3 protease.

Z. Ni, Suoming Zhang, S. Baker, 2010, Bioorganic & medicinal chemistry letters.

4-bromo-1-methoxy-N-[2-(4-aryl-1-piperazinyl)ethyl]-2-naphthalenecarboxamides: Selective dopamine D3 receptor partial agonists

Stephen J. Johnson, T. Heffner, H. Akunne, 1996 .

Discovery of selective dopamine D3 ligands: II. 2-[4-[3-(4-aryl-1-piperazinyl)propoxy]phenyl]benzimidazole partial agonists

T. Heffner, R. Mackenzie, L. Wise, 1995 .

REACTION OF CERIUM(IV) AMMONIUM NITRATE WITH 3‐METHYLCEPHALOSPORINS: SYNTHESIS OF A 2‐METHOXY‐3‐METHYLCEPHALOSPORIN

Jon L. Wright, S. Roberts, R. Fletton, 1985 .

Discovery of selective dopamine D3 ligands: I. Dimeric 2-[4-(3-aminopropoxy)phenyl]benzimidazole antagonists

T. Heffner, D. Downing, R. Mackenzie, 1995 .

The synthesis of trisubstituted tetrahydrofurans via the use of an organoselenium-mediated cyclisation reaction

David J. Williams, S. Ley, G. Brussani, 1986 .

3-arylimino-2-indolones are potent and selective galanin GAL3 receptor antagonists.

T. Blackburn, B. Lagu, H. Akunne, 2006, Journal of medicinal chemistry.

Subtype selective NMDA receptor antagonists: evaluation of some novel alkynyl analogues.

Jon L. Wright, L. Meltzer, S. Nikam, 2004, Bioorganic & medicinal chemistry letters.

Synthesis and SAR of acyclic HCV NS3 protease inhibitors with novel P4-benzoxaborole moieties.

Z. Ni, Suoming Zhang, S. Baker, 2011, Bioorganic & medicinal chemistry letters.

8-Amino-6-(arylsulphonyl)-5-nitroquinolines: Novel nonpeptide neuropeptide Y1 receptor antagonists

T. Heffner, D. Downing, J. C. Hodges, 1996 .

Design and discovery of neuropeptide Y1 receptor antagonists

Jon L. Wright, 1997 .

8‐Amino‐6‐(arylsulfonyl)‐5‐nitroquinolines: Novel Nonpeptide Neuropeptide Y1 Receptor Antagonists.

T. Heffner, D. Downing, J. C. Hodges, 1996 .

Novel macrocyclic HCV NS3 protease inhibitors derived from α-amino cyclic boronates.

William McDowell, Yang Liu, Dazhong Fan, 2010, Bioorganic & medicinal chemistry letters.

Pharmacological Characterization of PD 152255, a Novel Dimeric Benzimidazole Dopamine D3 Antagonist

T. Heffner, H. Akunne, L. Wise, 1998, Pharmacology Biochemistry and Behavior.